CN102626507A - Traditional Chinese medicine for curing uterine fibroid - Google Patents
Traditional Chinese medicine for curing uterine fibroid Download PDFInfo
- Publication number
- CN102626507A CN102626507A CN2012101200519A CN201210120051A CN102626507A CN 102626507 A CN102626507 A CN 102626507A CN 2012101200519 A CN2012101200519 A CN 2012101200519A CN 201210120051 A CN201210120051 A CN 201210120051A CN 102626507 A CN102626507 A CN 102626507A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- traditional chinese
- uterine fibroid
- curing
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to the field of traditional Chinese medicine, in particular to a traditional Chinese medicine for curing uterine fibroid, which is composed of astragalus mongholicus, rhizoma sparganii, curcuma zedoary, cattail pollen, trogopterus dung, seaweed, liquorice, grilled turtle shell, manis pentadactyla pearl, oyster, selfheal, roasted rhizoma atractylodis macrocephalae, pseudobulbus cremastrae seu pleiones and achyranthes bidentata. The traditional Chinese medicine for curing uterine fibroid has the advantages of being good in curative effect on uterine fibroid, high in cure rate, free of any toxic and side effects and the like. Effective rate is 95%, and cure rate is 60%.
Description
Technical field:
The present invention relates to the field of Chinese medicines, is a kind of Chinese medicine of treating hysteromyoma specifically.
Background technology:
Doctor trained in Western medicine is thought: the reason that hysteromyoma takes place is relevant with estrogenic stimulation.Primary disease still lacks a kind of comparatively ideal Therapeutic Method up to now except operation.
The traditional Chinese medical science belongs to primary disease within the lump in the abdomen category.The reason of its morbidity is how relevant with the stagnation of QI and blood stasis.Jing Yue's complete work says that (blood stasis is detained and is done disease, and only the married woman has it.Its disease is by menstrual period, or puerperal, all internal injury raw food, or have a cold outward; Or be enraged the impairing the liver QI rising in reverse order and stay, or the melancholy impairing the spleen deficiency of vital energy and stasis, or decrease a little less than the long-pending stasis of blood gas of labor not all right) or the spleen kidney deficiency, dysfunction of the spleen in transportation; Water is wet interior stagnant, gathers to form expectorant, and the stagnation of phlegm collaterals of the uterus is tied with QI and blood mutually, amasss to form disease.According to disease caused by accumulations of pathogen should be treated with therapy of dispersion, hard masses should be resolved gradually, the treating excess syndrome with purgative methods, treatment of deficiency-syndrome by reinforcement's principle, the author is with the method treatment primary disease of reinforcement and elimination in combination, and curative effect is fast, and cure rate is high, acomia incumbent what toxic and side effects.
Modern pharmacology research thinks that blood circulation promoting and blood stasis dispelling side's medicine can play the effect of expansion and adjustment to uterine smooth muscle, can promote the fibrosis organization softening to absorb with recovering, and can adjust some endocrine disturbance, so to the primary disease good effect.
Summary of the invention:
The objective of the invention is provides a kind of good effect for solving the deficiency of above-mentioned technology, and cure rate is high, and is without any side effects, can effectively treat the Chinese medicine of hysteromyoma.
For realizing above-mentioned purpose, a kind of Chinese medicine of treating hysteromyoma is characterized in that being made up of the following raw materials in weight drug ratio: Radix Astragali 30-35g, triangular 15-20g, Rhizoma Curcumae 15-20g, Pollen Typhae 15-20g, Oletum Trogopterori 15-20g, Sargassum 30-35g, Radix Glycyrrhizae 10-15g; Carapax Trionycis (processed) 30-35g, Squama Manis pearl 10-15g, Concha Ostreae 40-45g; Spica Prunellae 30-35g; Rhizoma Atractylodis Macrocephalae (parched) 25-30g, Pseudobulbus Cremastrae Seu Pleiones 10-15g, Radix Achyranthis Bidentatae 15-20g.
Pharmacology analysis: the Radix Astragali, Gan Wen goes into the spleen lung meridian, has the property of hair growth promoting, so can QI invigorating give birth to sun; Triangular, bitter flat, go into the liver spleen channel, removing blood stasis circulation of qi promoting, removing food stagnancy pain relieving; Rhizoma Curcumae, the toil temperature is gone into the liver spleen channel, circulation of qi promoting removing blood stasis, removing food stagnancy pain relieving; Pollen Typhae, sweet flat, go into liver pericardium channel, give birth to and use the promoting the circulation of blood repercussive; Oletum Trogopterori, Gan Wen goes into Liver Channel, promoting blood circulation, eliminating stasis to stop pain; Sargassum, bitter salty-cold, go into liver stomach kidney channel, the repercussive eliminating stagnation; Radix Glycyrrhizae, sweet flat, go into taste cardiopulmonary warp, heat-clearing and toxic substances removing, the mediation property of medicine; Carapax Trionycis (processed), salty-cold, go into the liver spleen channel, the merit of hard masses softening and resolving is arranged; The Squama Manis pearl, salty, be slightly cold, go into liver stomach warp, salty ability softening the hard mass, property is apt to away
String, can reach meridians thoroughly, through sick institute; Concha Ostreae, salty and bitter, be slightly cold, go into the Liver and kidney warp, ability hard masses softening and resolving; Spica Prunellae, toil is cold, goes into the liver and gall warp, the eliminating stagnation of relieving inflammation or internal heat; Rhizoma Atractylodis Macrocephalae (parched), the sweetness and bitterness temperature is gone into the taste warp, invigorating the spleen and replenishing QI; Pseudobulbus Cremastrae Seu Pleiones, Gan Weixin is cold, and is slightly poisonous, returns liver lung stomach spleen channel, dispersing swelling and dissipating binds, heat-clearing and toxic substances removing reduces phlegm; Radix Achyranthis Bidentatae, picric acid is flat, goes into the Liver and kidney warp, blood circulation promoting and blood stasis dispelling, tonifying liver and kidney and strengthening bones and muscles, conducting blood to flow downwards.More than all medicines share, inrigorating qi and promoting blood circulation is arranged, spleen reinforcing expectorant, the merit of hard masses softening and resolving.It is effective, without any side effects to be used to treat hysteromyoma.
Preparation, instructions of taking and consumption: get provided by the invention in medicinal cold water soak after 1 hour, be fried boiling earlier Squama Manis pearl and Carapax Trionycis (processed) 30 minutes reenter remaining all medicines.First pass elder generation intense fire boils, and slow fire boiled 40 minutes again, leached 150ml; Second time intense fire boils, and slow fire boiled 50 minutes again, leached 150ml, twice medicine juice mix 300ml.In each decoction being taken warmly 150ml half an hour ante cibum morning and evening.
Prescription of the present invention is prohibited clothes when menstrual phase or incessant dripping of menstrual blood.
In the prescription of the present invention, Sargassum and Radix Glycyrrhizae be usefulness on the contrary mutually, but the treatment hysteromyoma is effective, does not find any toxic and side effects.
Beneficial effect of the present invention: can cure effective percentage 95%, cure rate 60% two to four courses of treatment of taking medicine.
The specific embodiment:
Below in conjunction with embodiment the present invention is further specified:
Embodiment 1: a kind of Chinese medicine of treating hysteromyoma, form by the component of following raw materials in weight drug ratio: Radix Astragali 35g, triangular 20g, Rhizoma Curcumae 20g, Pollen Typhae 20g, Oletum Trogopterori 20g, Sargassum 35g, Radix Glycyrrhizae 15g, Carapax Trionycis (processed) 35g; Squama Manis pearl 15g; Concha Ostreae 45g, Spica Prunellae 35g, Rhizoma Atractylodis Macrocephalae (parched) 30g; Pseudobulbus Cremastrae Seu Pleiones 15g, Radix Achyranthis Bidentatae 20g.
Embodiment 2: a kind of Chinese medicine of treating hysteromyoma, and wherein the preferred weight proportioning of various material medicines is: Radix Astragali 30g, triangular 15g, Rhizoma Curcumae 15g, Pollen Typhae 15g, Oletum Trogopterori 15g, Sargassum 30g, Radix Glycyrrhizae 10g, Carapax Trionycis (processed) 30g; Squama Manis pearl 10g; Concha Ostreae 40g, Spica Prunellae 30g, Rhizoma Atractylodis Macrocephalae (parched) 25g; Pseudobulbus Cremastrae Seu Pleiones 10g, Radix Achyranthis Bidentatae 20g.
Clinical efficacy is summed up:
One, physical data: Chinese medicine of the present invention is applied to clinical for many years, treats tens of routine patients.Oldest 46 years old, minimum 27 years old.7 * 6.8 * 6.3cm that hysteromyoma is maximum, 1.1 * 0.8 minimum * 0.7cm.
Two, diagnosis:
1, gynecologial examination is made a definite diagnosis.
2, make a definite diagnosis with ultrasound diagnosis.
Three, boil medicine, method of administration and consumption.
Medicinal cold water soak is after 1 hour in of the present invention, boils earlier Asteriscus Pseudosciaenae, Carapax Trionycis (processed) half an hour with high heat, adds remaining Chinese medicine again; Intense fire boils; Change 40 minutes after-filtration of slow fire boiling and go out medicinal liquid 150ml, after remaining medicine adds the suitable quantity of water intense fire and boils, change slow fire boiling and leach medicinal liquid 150ml after 50 minutes again; Twice gained medicinal liquid mixed 300ml altogether, early, respectively take 150ml half an hour after the supper.
Be 1 course of treatment generally, take medicine two courses of treatment of minimum person, at most four courses of treatment of persons with one month.
Four, curative effect determinate standard:
Recovery from illness case: make a definite diagnosis the muscular tumor complete obiteration through B ultrasonic and gynecologial examination.
Produce effects case: make a definite diagnosis muscular tumor through B ultrasonic and gynecologial examination and dwindle more than the 1.5cm.
Effective case: make a definite diagnosis muscular tumor through B ultrasonic and gynecologial examination and dwindle below the 1.5cm.
Invalid case: make a definite diagnosis muscular tumor size no change or increase through B ultrasonic and gynecologial examination.
Five, therapeutic effect:
Take this Chinese medicine with the statistics that is as the criterion 3 courses of treatment, cure rate 60%, obvious effective rate 25%, effective percentage 10%, invalid 5%.
Six, model case:
Case 1: high * *, 30 years old, routine physical examination in August calendar year 2001,2 of fleshy polyps are found in ultrasound diagnosis.1.2 * 0.8 big * 0.6cm, 1.1 * 0.7 little * 0.8cm.So take side of the present invention, take a course of treatment after, ultrasound diagnosis, fleshy polyp disappears.For anti-recurrence, take again and consolidate curative effect a course of treatment.Follow up a case by regular visits to not recurrence so far.
Case 2: in * *, 40 years old, first visit in November, 2000.The patient makes a definite diagnosis intramural myoma, tumor body 6 * 5.3 * 4.8cm in third-class first class hospital the year before.Clothes Ramulus Cinnamomi Poria ball electuary, effect is bad.So, take side of the present invention.After the course of treatment, ultrasound diagnosis, produce effects.Patient's confidence heightens, continues again to take medicine 2 courses of treatment, and ultrasound diagnosis, muscular tumor disappears.
Claims (1)
1. a Chinese medicine of treating hysteromyoma is characterized in that being made up of the following raw materials in weight drug ratio: Radix Astragali 30-35g, triangular 15-20g, Rhizoma Curcumae 15-20g, Pollen Typhae 15-20g, Oletum Trogopterori 15-20g, Sargassum 30-35g, Radix Glycyrrhizae 10-15g, Carapax Trionycis (processed) 30-35g; Squama Manis pearl 10-15g; Concha Ostreae 40-45g, Spica Prunellae 30-35g, Rhizoma Atractylodis Macrocephalae (parched) 25-30g; Pseudobulbus Cremastrae Seu Pleiones 10-15g, Radix Achyranthis Bidentatae 15-20g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012101200519A CN102626507A (en) | 2011-09-30 | 2012-04-24 | Traditional Chinese medicine for curing uterine fibroid |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110309268XA CN102343075A (en) | 2011-09-30 | 2011-09-30 | Traditional Chinese medicine for treating hysteromyoma |
| CN201110309268.X | 2011-09-30 | ||
| CN2012101200519A CN102626507A (en) | 2011-09-30 | 2012-04-24 | Traditional Chinese medicine for curing uterine fibroid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102626507A true CN102626507A (en) | 2012-08-08 |
Family
ID=45542396
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201110309268XA Withdrawn CN102343075A (en) | 2011-09-30 | 2011-09-30 | Traditional Chinese medicine for treating hysteromyoma |
| CN2012101200519A Pending CN102626507A (en) | 2011-09-30 | 2012-04-24 | Traditional Chinese medicine for curing uterine fibroid |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201110309268XA Withdrawn CN102343075A (en) | 2011-09-30 | 2011-09-30 | Traditional Chinese medicine for treating hysteromyoma |
Country Status (1)
| Country | Link |
|---|---|
| CN (2) | CN102343075A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106492126A (en) * | 2016-12-09 | 2017-03-15 | 首都医科大学 | A kind of for treating Chinese medicine preparation of hysteromyoma and preparation method thereof |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103735849B (en) * | 2014-01-24 | 2016-02-17 | 林丽娟 | A kind of medicine and preparation method for the treatment of hysteromyoma |
-
2011
- 2011-09-30 CN CN201110309268XA patent/CN102343075A/en not_active Withdrawn
-
2012
- 2012-04-24 CN CN2012101200519A patent/CN102626507A/en active Pending
Non-Patent Citations (1)
| Title |
|---|
| 李虹，等: "子宫肌瘤的中医药治疗进展", 《临床合理用药》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106492126A (en) * | 2016-12-09 | 2017-03-15 | 首都医科大学 | A kind of for treating Chinese medicine preparation of hysteromyoma and preparation method thereof |
| CN106492126B (en) * | 2016-12-09 | 2019-10-01 | 首都医科大学 | A kind of Chinese materia medica preparation and preparation method thereof for treating fibroid |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102343075A (en) | 2012-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101897755A (en) | Traditional Chinese medicine preparation for regulating fat, invigorating blood circulation and regulating vital energy and preparation method thereof | |
| CN103550695B (en) | Medicament for treating breast cancer | |
| CN102755626B (en) | Traditional Chinese medicine combination for treating sinus sick syndrome and preparation method | |
| CN104740041A (en) | Traditional Chinese medicine oral decoction for treating constipation | |
| CN108837106A (en) | A kind of drug that treating goat and preparation method | |
| CN102580050B (en) | Externally applied traditional Chinese medicine combination for treating chronic pelvic inflammatory disease through applying iontophoresis and preparation method | |
| CN104922281A (en) | Traditional Chinese medicine composition of patch-type ointment for treating slow-transit constipation and preparation method thereof | |
| CN103223142A (en) | Traditional Chinese medicine for treating mastopathy | |
| CN103083617B (en) | Traditional Chinese medicine for treating hyperplasia of prostate | |
| CN103083616B (en) | Traditional Chinese medicine for treating ovarian cyst | |
| CN102908555A (en) | Chinese medicament for treating edema | |
| CN102626507A (en) | Traditional Chinese medicine for curing uterine fibroid | |
| CN105727117A (en) | Medicine for treating prostatic hyperplasia and preparation method thereof | |
| CN102133369B (en) | Traditional Chinese medicine composition for treating acute cholecystitis | |
| CN104721758A (en) | Pharmaceutical for treating ovarian cyst and preparing method thereof | |
| CN101204494B (en) | Medicine for chronic enteritis | |
| CN103705801A (en) | Chinese medicament decoction for treating hyperostosis | |
| CN104740288A (en) | Traditional Chinese medicine composition for treating constipation | |
| CN103920104A (en) | Traditional Chinese medicinal composition for treating uterine bleeding syndrome of puerperal coagulated phlegm in uterus | |
| CN104352803A (en) | Traditional Chinese medicinal preparation for treating stomach cancer | |
| CN104056172A (en) | Traditional Chinese medicine composition for treating stomach diseases and preparation method of traditional Chinese medicine composition capsules | |
| CN103845644A (en) | Medicinal composition for treating verruca plana | |
| CN104257813B (en) | A kind of Chinese medicine composition of QI and blood regulating and preparation method thereof | |
| CN104258058A (en) | Traditional Chinese medicine for treating juvenile canities | |
| CN106256372A (en) | A kind of endo-medicine treating chronic prostatitis and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120808 |